
Genomics in the NHS
This #GenomicsConversation week, we look at the genomics landscape in the UK today and the 10-year plan for the future

Covid-19 contributes to antimicrobial resistance crisis
Covid-19 can’t be treated with antibiotics, so why are patients receiving them and what impact could this have on human health?

Global genomes sequenced in new study
Genomic datasets are widely used by researchers, but are they representative enough? We look at recent research that aims to shift the balance

New drug target identified for colorectal cancer
Around 15% of colorectal cancers are resistant to standard therapies but ‘switching off’ a specific gene could offer new avenues for treatment

Genomics overturns understanding of PCOS
It is now understood that men can be affected by the condition, so what does this mean for treatment?

NHS launches new polygenic scores trial for heart disease
A new approach in personalised medicine aims to use genomics to improve risk prediction for cardiovascular disease

Are we there yet? Genome sequencing turns 20
We look back on two decades of genome sequencing and explore four areas where continued progress could provide future breakthroughs

Transcriptomics and mental illness
We look beyond the genome to find out how RNA can impact on the presentation of psychiatric conditions

NHS to trial new multi-cancer blood test
More than 50 different types of cancer can be detected by the new test, but how will it work?

The importance of diversity in genomic datasets
We look at a recent prostate cancer study that highlights the importance of inclusivity in genomic studies

Filling the gaps: sequencing a chromosome
A human chromosome has been sequenced in its entirety for the first time, but why is this breakthrough important for the future of our reference genome?

Richter’s syndrome study published
A new study by GEP fellow Niamh Appleby has found potential pathways and targets for the treatment of Richter’s syndrome – an aggressive form of adult leukaemia